Citation: | MU S C, SUN Z, SONG Z J. Characteristics of the expression of CX3CR1 in natural killer cells from peripheral blood and its association with gut microbiota in sepsis patients[J]. Chin J Clin Med, 2024, 31(6): 851-859. DOI: 10.12025/j.issn.1008-6358.2024.20241168 |
To explore the changes in the expression of CX3CR1 in natural killer (NK) cells from peripheral blood mononuclear cells (PBMC) in sepsis patients and its association with gut microbiota.
A total of 24 sepsis patients were selected from January 2020 to January 2021 at Zhongshan Hospital, Fudan University, and 10 healthy volunteers were recruited in January 2021 as healthy controls. Fecal samples and peripheral blood were collected from sepsis patients on the first and fourth days of hospitalization. Sequencing of the V3-4 region of the 16S rDNA gene of gut microbiota was performed using the Illumina MiSeq platform. The peripheral blood samples were isolated by positively selected magnetic beads, and the CD3-CD56+NK cells were identified by flow cytometry. The mRNA expression of CX3CR1 was detected by qPCR, and the changes in CX3CR1 expression and its correlation with gut microbiota were analyzed.
Compared with healthy control group, the Shannon diversity index of the gut microbiota and the proportion of Firmicutes in sepsis patients decreased; compared with admission day, the Shannon diversity of the gut microbiota in sepsis patients on the fourth day of hospitalization significantly decreased, the proportion of Proteobacteria on phylum level and the relative abundance of Enterococcus and Klebsiella on genus level significantly increased. The CX3CR1 expression of PBMC-NK cells in sepsis patients on the fourth day was significantly lower than that on the admission day (P<0.001). Compared with surviving patients, CX3CR1 expression in non-surviving patients significantly decreased on the fourth day (P<0.05). Spearman correlation analysis showed that CX3CR1 expression of PBMC-NK cells was positively correlated with the quantity of gut microbiota and the Shannon diversity index (P<0.01).
The expression of CX3CR1 in PBMC-NK cells in sepsis patients decreases with disease progression, and is related to prognosis. Furthermore, its expression is found to be closely related to the gut microbiota.
[1] |
CHEN A X, SIMPSON S Q, PALLIN D J. Sepsis guidelines[J]. N Engl J Med, 2019, 380(14): 1369-1371. DOI: 10.1056/NEJMclde1815472
|
[2] |
RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. DOI: 10.1016/S0140-6736(19)32989-7
|
[3] |
LIU D, HUANG S Y, SUN J H, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options[J]. Mil Med Res, 2022, 9(1): 56.
|
[4] |
LASKOWSKI T J, BIEDERSTÄDT A, REZVANI K. Natural killer cells in antitumour adoptive cell immunotherapy[J]. Nat Rev Cancer, 2022, 22(10): 557-575. DOI: 10.1038/s41568-022-00491-0
|
[5] |
DARDEN D B, DONG X R, BRUSKO M A, et al. A novel single cell RNA-seq analysis of non-myeloid circulating cells in late sepsis[J]. Front Immunol, 2021, 12: 696536. DOI: 10.3389/fimmu.2021.696536
|
[6] |
MARQUARDT N, KEKÄLÄINEN E, CHEN P R, et al. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69-CD56dim cells[J]. J Allergy Clin Immunol, 2017, 139(4): 1321-1330. e4.
|
[7] |
LEONARDI I, LI X, SEMON A, et al. CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi[J]. Science, 2018, 359(6372): 232-236. DOI: 10.1126/science.aao1503
|
[8] |
CHOUSTERMAN B G, BOISSONNAS A, POUPEL L, et al. Ly6Chigh monocytes protect against kidney damage during sepsis via a CX3CR1-dependent adhesion mechanism[J]. J Am Soc Nephrol, 2016, 27(3): 792-803. DOI: 10.1681/ASN.2015010009
|
[9] |
SCIUMÈ G, ANGELIS G D, BENIGNI G, et al. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow[J]. Blood, 2011, 117(17): 4467-4475. DOI: 10.1182/blood-2010-07-297101
|
[10] |
HAMANN I, UNTERWALDER N, CARDONA A E, et al. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells[J]. Immunology, 2011, 133(1): 62-73. DOI: 10.1111/j.1365-2567.2011.03409.x
|
[11] |
HUANG D R, SHI F D, JUNG S, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system[J]. FASEB J, 2006, 20(7): 896-905. DOI: 10.1096/fj.05-5465com
|
[12] |
JIANG P L, JIA H Y, QIAN X Y, et al. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B[J]. Hepatology, 2024, 79(1): 167-182. DOI: 10.1097/HEP.0000000000000524
|
[13] |
KONDO Y, KIMURA O, TANAKA Y, et al. Differential expression of CX3CL1 in hepatitis B virus-replicating hepatoma cells can affect the migration activity of CX3CR1+ immune cells[J]. J Virol, 2015, 89(14): 7016-7027. DOI: 10.1128/JVI.00716-15
|
[14] |
PATEL A, JAGADESHAM V P, PORTER K E, et al. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease[J]. Eur J Vasc Endovasc Surg, 2008, 36(1): 20-27. DOI: 10.1016/j.ejvs.2008.01.014
|
[15] |
HAAK B W, WIERSINGA W J. The role of the gut microbiota in sepsis[J]. Lancet Gastroenterol Hepatol, 2017, 2(2): 135-143. DOI: 10.1016/S2468-1253(16)30119-4
|
[16] |
MU S C, XIANG H, WANG Y Z, et al. The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut[J]. Crit Care, 2022, 26(1): 68. DOI: 10.1186/s13054-022-03943-z
|
[17] |
LONG X Y, MU S C, ZHANG J, et al. Global signatures of the microbiome and metabolome during hospitalization of septic patients[J]. Shock, 2023, 59(5): 716-724. DOI: 10.1097/SHK.0000000000002117
|
[18] |
SHANKAR-HARI M, PHILLIPS G S, LEVY M L, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 775-787. DOI: 10.1001/jama.2016.0289
|
[19] |
UBEDA C, TAUR Y, JENQ R R, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans[J]. J Clin Invest, 2010, 120(12): 4332-4341. DOI: 10.1172/JCI43918
|
[20] |
WALKER A W, INCE J, DUNCAN S H, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota[J]. ISME J, 2011, 5(2): 220-230. DOI: 10.1038/ismej.2010.118
|
[21] |
BRANDL K, PLITAS G, SCHNABL B, et al. MyD88-mediated signals induce the bactericidal lectin RegⅢ gamma and protect mice against intestinal Listeria monocytogenes infection[J]. J Exp Med, 2007, 204(8): 1891-1900. DOI: 10.1084/jem.20070563
|
[22] |
KIM S, COVINGTON A, PAMER E G. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens[J]. Immunol Rev, 2017, 279(1): 90-105. DOI: 10.1111/imr.12563
|
[23] |
SCHULTHESS J, PANDEY S, CAPITANI M, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages[J]. Immunity, 2019, 50(2): 432-445. e7.
|
[24] |
NIESS J H, BRAND S, GU X B, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance[J]. Science, 2005, 307(5707): 254-258. DOI: 10.1126/science.1102901
|
[25] |
KOSCSÓ B, KURAPATI S, RODRIGUES R R, et al. Gut-resident CX3CR1hi macrophages induce tertiary lymphoid structures and IgA response in situ[J]. Sci Immunol, 2020, 5(46): eaax0062. DOI: 10.1126/sciimmunol.aax0062
|
[26] |
FRIGGERI A, CAZALIS M A, PACHOT A, et al. Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients[J]. Crit Care, 2016, 20(1): 204. DOI: 10.1186/s13054-016-1362-x
|